859 Unicorns. 30 Exits. Do the Math.

Q1 2026 set every funding record ever recorded. Then Q2 opened and the market had to reckon with what it actually built. The NVCA's yearbook landed Monday with a verdict that cuts through the celebration: 859 unicorns, $4.34 trillion in paper value, and roughly 30 to 40 of them actually exited last year. Capital deployment has never been stronger. Liquidity has never been more broken. Something has to give.

SiFive raised $400M in a Series G at $3.65B, led by Atreides, with Nvidia, Apollo, D1, Point72, and T. Rowe Price in the syndicate. CEO Patrick Little called it the company's final private round before an IPO. The timing is not accidental. Arm launched its own in-house silicon in March, turning itself from a neutral IP licensor into a direct competitor to the same hyperscalers it once served. SiFive, built on open-standard RISC-V, is suddenly the safe harbor. Nvidia backing a company whose chip architecture competes with the CPU ecosystem adjacent to its own GPUs tells you everything about where the smart money thinks the chip architecture wars are heading. Read More…

Hermeus closed a $350M Series C at a $1B valuation, led by Khosla Ventures with Founders Fund and RTX Ventures returning. The round is $200M equity and $150M debt — the CEO told TechCrunch the debt structure was deliberate, keeping dilution down while scaling manufacturing. The company builds high-Mach unmanned military aircraft and already flew Quarterhorse Mk 2.1 in March. Hermeus is also moving its HQ from Atlanta to El Segundo, LA. Defense tech is no longer a niche VC thesis. It is the thesis, and this round is further proof that hardware-first, iteration-heavy approaches to national security capabilities are attracting tier-one capital at scale. Read More…

The NVCA released its 2026 Yearbook on Monday with data that reframes Q1's record-breaking headlines. U.S. VC deployed $320B in 2025, up 51% year-over-year. But first-time fund formation collapsed to 101 funds, the lowest since 2011 and down 78% from the 457 launched in 2021. The top ten funds captured 33% of all VC capital. Non-traditional investors including hedge funds, sovereign wealth funds, and corporate strategics now account for 83% of all investment value. The industry is concentrating at every level simultaneously: fewer funds, fewer deals, bigger checks, and a liquidity backlog that keeps expanding. The exit market needs to open, and it needs to open soon. Read More…

859 Unicorns. 30 Exits. Do the Math.

The NVCA released its 2026 Yearbook on Monday, and buried inside the record-setting headlines is the most important structural tension in venture capital right now.

Start with the numbers that made the press releases: $320 billion deployed in 2025, up 51% year-over-year. AI captured 65% of all deal value. The Crunchbase Unicorn Board added $900 billion in paper value in Q1 2026 alone, the largest single-quarter gain on record. By almost every measure of capital deployment, the industry has never been more active.

Now look at the other side of the ledger. Venture-backed exits totaled $217 billion in 2025 across 1,463 deals, more than double the prior year but still far below the levels needed to address the backlog. There are currently 859 companies on the unicorn board, carrying a combined $4.34 trillion in paper valuation. Roughly 30 to 40 of them actually exited last year. At that pace, clearing the current inventory would take two decades.

The math compounds in a less obvious direction. Traditional VC fundraising totaled just $67 billion last year across 585 funds. The top ten funds took $22 billion of that, leaving $45 billion to be divided among the other 575. First-time fund formation hit 101 funds, the lowest number since 2011. Seventy-eight percent below the 2021 peak. The industry that created these unicorns is contracting at the very moment the unicorn count is expanding fastest.

What's actually holding the system together is non-traditional capital. Hedge funds, sovereign wealth funds, corporate strategics, and endowments now account for 83% of all investment value while participating in only 30% of deals. They're writing enormous checks into a small number of companies, keeping valuations elevated and providing the illusion of market health. The question is whether they're providing liquidity or deferring it.

Secondary markets are starting to fill the gap. More than $100 billion in secondary volume was recorded in 2025, putting it on par with IPO and M&A activity combined. Thirty-four percent of the top 100 most valuable private companies executed secondary transactions last year. LPs are finding liquidity where they can.

The IPO window matters more than it has in years. Four AI companies are lining up for the public markets in 2026: SpaceX targeting June at $1.75 trillion, OpenAI targeting Q4 near $1 trillion, Databricks at H2 with a $134B valuation, and Cerebras refiling at $15 to 22B in Q2. Together they represent a combined float that public markets have never been asked to absorb. If those offerings price well and trade well, the logjam starts to break. If they stumble, the secondary market gets a lot busier and valuations at the late stage start resetting hard.

The headline from the NVCA Yearbook is record investment. The story underneath it is an industry that built an enormous inventory of unrealized value and is now waiting for a market structure that can absorb it.

Starfish Space raised $111.7M in a Series B led by Point72 Ventures, with Activate Capital and Shield Capital co-leading. The company builds Otter, an autonomous spacecraft designed to rendezvous with satellites in orbit for life extension, repositioning, or deorbit. It has contracts with the U.S. Space Force, the Space Development Agency, NASA, and SES. The Pentagon is effectively co-investing alongside venture on the same hardware. That structure, dual-use capability meeting dual-use funding, is what satellite servicing being treated as a national security line item actually looks like. Read More…

Stipple Bio raised $100M in an oversubscribed Series A co-led by RA Capital, a16z Bio+Health, and Nextech Invest. The Cambridge biotech emerged from stealth to advance precision cancer therapies using its Pointillist Platform, which identifies tumor-specific epitopes to enable antibody-drug conjugates that hit cancer cells without damaging healthy tissue. Lead asset STP-100 targets the clinic in early 2027. The round funds the company into 2029. A16z Bio+Health co-leading alongside RA Capital is a signal that this is viewed as a genuine platform bet, not just another ADC play. Read More…

Chapter raised $100M in a Series E led by Generation Investment Management, with XYZ Venture Capital, Maverick Ventures, and 8VC participating. The company runs an AI-powered Medicare navigation platform that guides seniors through health coverage decisions. 65 million Americans are Medicare-eligible today. Most of them are navigating a system designed to be confusing. Chapter's bet is that AI advisory at the point of decision is worth more than generic comparison tools. Generation Investment leading signals this fits their thesis on sustainable healthcare infrastructure. Read More…

Modus raised $85M in a combined seed and Series A led by Lightspeed Venture Partners. The Philadelphia-based startup is building a tech-enabled audit platform that acquires CPA firms and equips them with AI-driven tools to deliver higher-quality audits. Think roll-up strategy meets AI workflow automation in a space that has seen almost no software disruption in decades. Lightspeed writing an $85M check into a seed and Series A together is an aggressive entry. The thesis: AI unlocks audit economics that make the CPA firm acquisition model actually work at scale. Read More…

Patlytics raised $40M in a Series B led by SignalFire. The New York company builds an end-to-end AI platform for the full patent lifecycle, from application drafting through infringement analysis and portfolio management. More than 40% of the Am Law 100 already uses the platform. The company reports an 80% reduction in project time for users and over $30K saved per claim chart. At $65M total raised in under two and a half years, this is one of the faster-scaling legal AI companies outside the Legora and Harvey tier. IP is the one vertical where generalist AI still falls short, and Patlytics is building toward the reason why.

The IPO pipeline is the market story of Q2, and the next few weeks will start setting the tone. SpaceX filed confidentially in early April targeting a June offering at a $1.75 trillion valuation. That's not a typo. If it prices anywhere near that range it will be the largest IPO in history by a significant margin, and it will set a reference point for every late-stage AI company trying to go public this year. Watch for early investor chatter about roadshow timing.

Cerebras re-filed its IPO documents after pulling them last fall, targeting a $15 to 22B valuation in Q2. The company's first attempt was blocked by national security concerns over Saudi Aramco's investment. Whether the regulatory environment has softened enough to let this one through is the question. Expect that to become a news cycle of its own in the next two to three weeks.

On the funding side, multiple sources suggest a wave of defense AI raises are in late-stage conversations, with at least two companies that were in the $500M to $1B valuation range looking to close before the summer. The Shield AI and Hermeus rounds this quarter have created room for smaller defense tech names to ask for more aggressive terms.

And worth watching: the tariff uncertainty that started rattling public markets last week has not yet shown up meaningfully in VC deal closings, but LP conversations are reportedly getting more cautious. If the macro noise persists into May, expect some late-stage closes to push, not collapse.